Donald S. Levy

856 total citations
25 papers, 274 citations indexed

About

Donald S. Levy is a scholar working on Genetics, Nutrition and Dietetics and Immunology. According to data from OpenAlex, Donald S. Levy has authored 25 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 6 papers in Nutrition and Dietetics and 6 papers in Immunology. Recurrent topics in Donald S. Levy's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers), Vitamin K Research Studies (6 papers) and Autoimmune Bullous Skin Diseases (5 papers). Donald S. Levy is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers), Vitamin K Research Studies (6 papers) and Autoimmune Bullous Skin Diseases (5 papers). Donald S. Levy collaborates with scholars based in United States, Germany and United Kingdom. Donald S. Levy's co-authors include John Anderson, Timothy Craig, William R. Lumry, Paul K. Keith, Juthaporn Cowan, Marc A. Riedl, Ingo Pragst, Michael Manning, Henriette Farkas and Antônio Condino‐Neto and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, The Journal of Pediatrics and American Journal of Ophthalmology.

In The Last Decade

Donald S. Levy

22 papers receiving 263 citations

Peers

Donald S. Levy
Maria Faßhauer Germany
Rabheh Abdul‐Aziz United States
Aimee Hanson Australia
Tiziana Coliva Italy
Simona Conte Sweden
Siris Patel India
Marc Sudman United States
Monica Maccaferri Italy
Magnun Nueldo Nunes Santos Brazil
V. Martínez Taboada Spain
Maria Faßhauer Germany
Donald S. Levy
Citations per year, relative to Donald S. Levy Donald S. Levy (= 1×) peers Maria Faßhauer

Countries citing papers authored by Donald S. Levy

Since Specialization
Citations

This map shows the geographic impact of Donald S. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald S. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald S. Levy more than expected).

Fields of papers citing papers by Donald S. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald S. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald S. Levy. The network helps show where Donald S. Levy may publish in the future.

Co-authorship network of co-authors of Donald S. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Donald S. Levy. A scholar is included among the top collaborators of Donald S. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald S. Levy. Donald S. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderson, John, Timothy Craig, Hilary Longhurst, et al.. (2025). Long-Term Efficacy Of Garadacimab For Hereditary Angioedema In Patients With Or Without Prior Exposure In A Phase 3 Open-Label Extension Study. Journal of Allergy and Clinical Immunology. 155(2). AB197–AB197.
2.
Levy, Donald S., et al.. (2025). Quality of life and burden of disease in patients with hereditary angioedema and their caregivers. Allergy and Asthma Proceedings. 46(5). 398–405. 1 indexed citations
3.
Craig, Timothy, Donald S. Levy, Avner Reshef, et al.. (2024). Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study. The Lancet Haematology. 11(6). e436–e447. 8 indexed citations
4.
Davis‐Lorton, Mark, et al.. (2024). Berotralstat Prophylaxis Reduces HAE Attack Rates Regardless of Baseline Attacks: Real-World Outcomes. Journal of Allergy and Clinical Immunology. 153(2). AB4–AB4. 2 indexed citations
5.
Lumry, William R., et al.. (2023). An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy. Allergy and Asthma Proceedings. 45(1). 44–49. 4 indexed citations
6.
7.
8.
9.
Levy, Donald S., Teresa Caballero, Iftikhar Hussaın, et al.. (2020). Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema. Pediatric Allergy Immunology and Pulmonology. 33(3). 136–141. 16 indexed citations
10.
Levy, Donald S., Henriette Farkas, Marc A. Riedl, et al.. (2020). Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial. Allergy Asthma and Clinical Immunology. 16(1). 8–8. 14 indexed citations
11.
Lumry, William R., et al.. (2020). Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy. Journal of Infusion Nursing. 43(3). 134–145. 3 indexed citations
12.
Levy, Donald S., et al.. (2020). Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review. Allergy Asthma and Clinical Immunology. 16(1). 41–41. 20 indexed citations
13.
Li, H. Henry, Bruce L. Zuraw, Hilary Longhurst, et al.. (2019). Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study. Allergy Asthma and Clinical Immunology. 15(1). 49–49. 9 indexed citations
14.
Lumry, William R., Timothy Craig, Bruce L. Zuraw, et al.. (2018). Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. The Journal of Allergy and Clinical Immunology In Practice. 6(5). 1733–1741.e3. 67 indexed citations
15.
LeGrys, Vicky A., et al.. (2009). A case of localized adrenergic urticaria mimicking an allergic reaction to a sweat chloride test. Pediatric Pulmonology. 44(9). 935–938. 4 indexed citations
16.
Ross, Gracious R., Donald M. Lloyd‐Jones, Donald S. Levy, et al.. (1999). Lifetime risk of developing coronary heart disease (multiple letters) [1]. 353(9156). 924–925. 3 indexed citations
17.
Pepose, Jay S., Brian Flowers, John A. Stewart, et al.. (1992). Herpesvirus Antibody Levels in the Etiologic Diagnosis of the Acute Retinal Necrosis Syndrome. American Journal of Ophthalmology. 113(3). 248–256. 35 indexed citations
18.
Levy, Donald S., Joseph A. Church, & Warren Richards. (1988). OKT4 epitope deficiency as a cause of reduced “helper” T cells in children at risk for human immunodeficiency virus infection. The Journal of Pediatrics. 113(1). 79–82. 4 indexed citations
19.
Church, Joseph A. & Donald S. Levy. (1988). 193 OKT-4 Epitope deficiency as a cause of reduced “helper” T-cells in patients (Pts) at risk for human immunodeficiency virus (HIV) infection. Journal of Allergy and Clinical Immunology. 81(1). 216–216. 1 indexed citations
20.
Levy, Donald S. & William F. Russell. (1959). The Effect of Topical Hydrocortisone Acetate Ointment at the Site of Intracutaneous Tuberculin Reaction. PubMed. 79(5). 666–668. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Faßhauer Breakdown of academic impact, for papers by Rabheh Abdul‐Aziz Breakdown of academic impact, for papers by Aimee Hanson Breakdown of academic impact, for papers by Tiziana Coliva Breakdown of academic impact, for papers by Simona Conte Breakdown of academic impact, for papers by Siris Patel Breakdown of academic impact, for papers by Marc Sudman Breakdown of academic impact, for papers by Monica Maccaferri Breakdown of academic impact, for papers by Magnun Nueldo Nunes Santos Breakdown of academic impact, for papers by V. Martínez Taboada
Rankless by CCL
2026